[1] |
RINGS D M, ROJKO J. Naturally occurring nasal obstructions in 11 sheep[J]. Cornell Vet, 1985, 75(2):269-276.
|
[2] |
APOSTOLIDI E D, PSALLA D, CHASSALEVRIS T, et al. Development of real-time PCR-based methods for the detection of enzootic nasal tumor virus 2 in goats[J]. Arch Virol, 2019, 164(3):707-716.
|
[3] |
林曦, 郝先谱, 赵振华, 等. 山羊鼻内腺瘤和腺癌的病理学研究[J]. 畜牧兽医学报, 1995, 26(5):456-461.LIN X, HAO X P, ZHAO Z H, et al. Pathological studies on intranasal adenoma and adenocarcinoma in goats[J]. Acta Veterinaria et Zootechnica Sinica, 1995, 26(5):456-461. (in Chinese)
|
[4] |
王景, 周曼, 何亚鹏, 等. 一起山羊地方性鼻内肿瘤的调查与诊断[J]. 动物医学进展, 2006, 38(2):129-132.WANG J, ZHOU M, HE Y P, et al. Diagnosis of enzootic nasal tumor in goats[J]. Progress in Veterinary Medicine, 2006, 38(2):129-132. (in Chinese)
|
[5] |
冯迎春, 颜其贵. 从山羊鼻内腺瘤病例中分离出嗜麦芽窄食单胞菌的报告[J]. 畜牧与兽医, 2009, 41(12):81-83.FENG Y C, YAN Q G. Report on the isolation of Stenotrophomonas maltophilia from cases of goat intranasal adenoma[J]. Animal Husbandry & Veterinary Medicine, 2009, 41(12):81-83. (in Chinese)
|
[6] |
何亚鹏, 张琪, 王景, 等. 山羊地方性鼻内肿瘤病毒gag蛋白的原核表达、纯化及多克隆抗体的制备[J]. 中国兽医学报, 2017, 37(12):2300-2303.HE Y P, ZHANG Q, WANG J, et al. Prokaryotic expression and purification of gag protein of enzootic nasal tumor virus of goats and preparation of its polyclonal antibody[J]. Chinese Journal of Veterinary Science, 2017, 37(12):2300-2303. (in Chinese)
|
[7] |
江锦秀, 林裕胜, 江斌, 等. 福建山羊地方性鼻内肿瘤的分子流行病学调查[J]. 福建农业学报, 2017, 32(8):837-841.JIANG J X, LIN Y S, JIANG B, et al. Molecular epidemiology of enzootic nasal tumor virus on goats in Fujian[J]. Fujian Journal of Agricultural Sciences, 2017, 32(8):837-841. (in Chinese)
|
[8] |
YE C, HUANG Q Y, CHEN T T, et al. First detection and genotypic analysis of goat enzootic nasal tumor virus 2 in Chongqing, China[J]. Arch Virol, 2019, 164(6):1647-1650.
|
[9] |
DE LAS HERAS M, ORTÍN A, COUSENS C, et al. Enzootic nasal adenocarcinoma of sheep and goats[J]. Curr Top Microbiol Immunol, 2003, 275(2):201-223.
|
[10] |
HE Y P, ZHANG Q, WANG J, et al. Full-length genome sequence analysis of enzootic nasal tumor virus isolated from goats in China[J]. Virol J, 2017, 14(1):141.
|
[11] |
WALSH S R, STINSON K J, MENZIES P I, et al. Development of an ante-mortem diagnostic test for enzootic nasal tumor virus and detection of neutralizing antibodies in host serum[J]. J Gen Virol, 2014, 95(8):1843-1854.
|
[12] |
DE CECCO B S, LORENZETT M P, HENKER L C, et al. Detection of enzootic nasal tumor virus (ENTV) in a sheep flock in southern Brazil[J]. Trop Anim Health Prod, 2019, 51(7):2095-2098.
|
[13] |
MAEDA N, INOSHIMA Y, DE LAS HERAS M, et al. Enzootic nasal tumor virus type 2 envelope of goats acts as a retroviral oncogene in cell transformation[J]. Virus Genes, 2021, 57(1):50-59.
|
[14] |
江锦秀, 林裕胜, 张靖鹏, 等. 山羊地方性鼻内肿瘤病毒ENTV-2FJ株的分离纯化和全基因组序列分析[J]. 农业生物技术学报, 2020, 28(2):313-324.JIANG J X, LIN Y S, ZHANG J P, et al. Isolation, purification and genome sequence analysis of enzootic nasal tumor virus of goats (Capra hircus) Strain ENTV-2FJ[J]. Journal of Agricultural Biotechnology, 2020, 28(2):313-324. (in Chinese)
|
[15] |
GOTTHARDT D, PUTZ E M, GRUNDSCHOBER E, et al. STAT5 is a key regulator in NK cells and acts as a molecular switch from tumor surveillance to tumor promotion[J]. Cancer Discov, 2016, 6(4):414-429.
|
[16] |
WINGELHOFER B, NEUBAUER H A, VALENT P, et al. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer[J]. Leukemia, 2018, 32(8):1713-1726.
|
[17] |
WANG X F, YANG J L, GUO G J, et al. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway[J]. Mol Cancer, 2019, 18(1):84.
|
[18] |
BRITSCHGI A, ANDRAOS R, BRINKHAUS H, et al. JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade:a rationale for cotargeting these pathways in metastatic breast cancer[J]. Cancer Cell, 2012, 22(6):796-811.
|
[19] |
HOHN O, MOSTAFA S, NORLEY S, et al. Development of an antigen-capture ELISA for the detection of the p27-CA protein of HERV-K(HML-2)[J]. J Virol Methods, 2016, 234:186-192.
|
[20] |
VERHOEVEN Y, TILBORGHS S, JACOBS J, et al. The potential and controversy of targeting STAT family members in cancer[J]. Semin Cancer Biol, 2020, 60:41-56.
|
[21] |
THOMAS S J, SNOWDEN J A, ZEIDLER M P, et al. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours[J]. Br J Cancer, 2015, 113(3):365-371.
|
[22] |
TOH T B, LIM J J, HOOI L, et al. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma[J]. J Hepatol, 2020, 72(1):104-118.
|
[23] |
BEMPT M V, DEMEYER S, BROUX M, et al. Cooperative enhancer activation by TLX1 and STAT5 drives development of NUP214-ABL1/TLX1-positive T cell acute lymphoblastic leukemia[J]. Cancer Cell, 2018, 34(2):271-285.
|
[24] |
BEDNARZ-MISA I, BROMKE M A, KRZYSTEK-KORPACKA M. Interleukin (IL)-7 signaling in the tumor microenvironment[M]//BIRBRAIR A. Tumor Microenvironment. Cham:Springer, 2021:9-49.
|
[25] |
VILLARINO A V, KANNO Y, O'SHEA J J. Mechanisms and consequences of Jak-STAT signaling in the immune system[J]. Nat Immunol, 2017, 18(4):374-384.
|